Expanded Access to ABBV-706

AbbVie

Status

Conditions: Small Cell Lung Cancer

Treatments: Drug: ABBV-706

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT07310277

C25-216

Details and patient eligibility

About

This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-706 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Exclusion Criteria:

• There are other suitable treatment options.
• The participant qualifies for ongoing clinical trials.